Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 3,390.97 | 1,632.13 | 2,917.15¢ | 16.7 | 2.1 | +8% | n/a | 0.0% |
| 31-Dec-27 | 3,705.67 | 1,747.12 | 3,079.16¢ | 15.8 | 2.8 | +6% | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
| Contracting | 06-Dec-2007 | Washington Post |
| United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
| Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 487.25 |
| Change Today | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $517.13 |
| 52 Week Low | $274.70 |
| Volume | 348,462 |
| Shares Issued | 43.56m |
| Market Cap | $21,226m |
| RiskGrade | 132 |
| Strong Buy | 6 |
| Buy | 3 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 15 |

You are here: research